Beacon Investment Advisory Services’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-2,062
Closed -$382K – 245
2024
Q4
$382K Sell
2,062
-5,910
-74% -$1.15M 0.02% 192
2024
Q3
$1.68M Sell
7,972
-603
-7% -$105K 0.07% 123
2024
Q2
$1.15M Sell
8,575
-172
-2% -$32.5K 0.05% 130
2024
Q1
$1.88M Buy
8,747
+254
+3% +$49.8K 0.08% 119
2023
Q4
$1.73M Sell
8,493
-652
-7% -$106K 0.08% 122
2023
Q3
$1.81M Buy
9,145
+8,429
+1,177% +$2.13M 0.09% 122
2023
Q2
$232K Buy
+716
New +$205K 0.01% 258
2023
Q1
– Sell
-849
Closed -$214K – 284
2022
Q4
$214K Buy
+849
New +$181K 0.01% 261
2022
Q2
– Sell
-911
Closed -$234K – 296
2022
Q1
$234K Buy
+911
New +$208K 0.01% 277

Other funds holding INSP

Beacon Investment Advisory Services's INSP Position: Q1 2025 in Review

Beacon Investment Advisory Services sold out of Inspire Medical Systems (INSP) in Q1 2025, closing a stake of 2,062 shares — an estimated $382K sold.

Beacon Investment Advisory Services first reported a position in INSP in Q1 2022 and held it in 9 quarters. The position peaked at $1.88M in Q1 2024. 363 funds tracked by Wall St. Rank hold INSP as of Q1 2025.

  • Beacon Investment Advisory Services reported no remaining Inspire Medical Systems position as of Q1 2025 after selling out during the quarter.
  • Beacon Investment Advisory Services sold 2,062 Inspire Medical Systems shares in Q1 2025, an estimated $382K.
  • Beacon Investment Advisory Services first reported a position in Inspire Medical Systems in Q1 2022 and held it in 9 quarters.
  • Beacon Investment Advisory Services's Inspire Medical Systems position peaked at $1.88M in Q1 2024.
  • 363 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2025.

Based on Beacon Investment Advisory Services's 13F filing for Q1 2025, filed 6 May 2025.